Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,034 | 12,589 | 15,979 | 19,145 | 22,028 |
| Receivables | 871 | 863 | 296 | 228 | 621 |
| Other current assets | 819 | 690 | 770 | 1,260 | 771 |
| TOTAL | $27,724 | $14,142 | $17,045 | $20,633 | $23,419 |
| Non-Current Assets | |||||
| PPE Net | 21 | N/A | N/A | N/A | N/A |
| Intangibles | 40 | 42 | 43 | 44 | 45 |
| TOTAL | $61 | $42 | $43 | $44 | $45 |
| Total Assets | $27,785 | $14,184 | $17,088 | $20,677 | $23,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,940 | 2,122 | 2,957 | 2,754 | 2,405 |
| TOTAL | $2,940 | $2,122 | $2,957 | $2,754 | $2,405 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,125 | 8,214 | 450 | 455 | 1,051 |
| TOTAL | $8,125 | $8,214 | $450 | $455 | $1,051 |
| Total Liabilities | $11,066 | $10,336 | $3,407 | $3,209 | $3,456 |
| Shareholders' Equity | |||||
| Common Shares | 82,315 | 74,815 | 74,119 | 75,219 | 75,067 |
| Retained earnings | -80,438 | -78,909 | -67,964 | -65,263 | -62,362 |
| Other shareholders' equity | 7,214 | 14 | 29 | 22 | 27 |
| TOTAL | $16,719 | $3,848 | $13,681 | $17,468 | $20,008 |
| Total Liabilities And Equity | $27,785 | $14,184 | $17,088 | $20,677 | $23,464 |